259 related articles for article (PubMed ID: 24673570)
1. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles.
Zhang J; Zhu X; Jin Y; Shan W; Huang Y
Mol Pharm; 2014 May; 11(5):1520-32. PubMed ID: 24673570
[TBL] [Abstract][Full Text] [Related]
2. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
3. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
4. The transport mechanism of integrin αvβ3 receptor targeting nanoparticles in Caco-2 cells.
Xu Y; Xu J; Shan W; Liu M; Cui Y; Li L; Liu C; Huang Y
Int J Pharm; 2016 Mar; 500(1-2):42-53. PubMed ID: 26784984
[TBL] [Abstract][Full Text] [Related]
5. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
6. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
Zhang P; Xu Y; Zhu X; Huang Y
Int J Pharm; 2015 Dec; 496(2):993-1005. PubMed ID: 26541299
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of cellular uptake and transport mediated by integrin receptor targeting trimethyl chitosan nanoparticles].
Xu J; Liu C; Xu YN; Shan W; Liu M; Huang Y
Yao Xue Xue Bao; 2015 Jul; 50(7):893-8. PubMed ID: 26552153
[TBL] [Abstract][Full Text] [Related]
8. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
Fan T; Chen C; Guo H; Xu J; Zhang J; Zhu X; Yang Y; Zhou Z; Li L; Huang Y
Eur J Pharm Biopharm; 2014 Oct; 88(2):518-28. PubMed ID: 24968819
[TBL] [Abstract][Full Text] [Related]
10. Chitosan/sodium tripolyphosphate nanoparticles as efficient vehicles for enhancing the cellular uptake of fish-derived peptide.
Zhao Y; Du W; Wu H; Wu M; Liu Z; Dong S
J Food Biochem; 2019 Feb; 43(2):e12730. PubMed ID: 31353647
[TBL] [Abstract][Full Text] [Related]
11. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
14. Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin.
Chen J; Liu C; Shan W; Xiao Z; Guo H; Huang Y
J Microencapsul; 2015; 32(7):632-41. PubMed ID: 26401551
[TBL] [Abstract][Full Text] [Related]
15. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.
Li X; Wang C; Liang R; Sun F; Shi Y; Wang A; Liu W; Sun K; Li Y
Pharm Res; 2015 Mar; 32(3):1017-27. PubMed ID: 25270570
[TBL] [Abstract][Full Text] [Related]
16. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
17. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.
Langston Suen WL; Chau Y
J Pharm Pharmacol; 2014 Apr; 66(4):564-73. PubMed ID: 24635558
[TBL] [Abstract][Full Text] [Related]
18. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
19. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan.
Chiu YL; Ho YC; Chen YM; Peng SF; Ke CJ; Chen KJ; Mi FL; Sung HW
J Control Release; 2010 Aug; 146(1):152-9. PubMed ID: 20580915
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan-hyaluronan substrates.
Hsu SH; Ho TT; Tseng TC
Biomaterials; 2012 May; 33(14):3639-50. PubMed ID: 22364729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
